Suppr超能文献

通过外源性酶在体内激活抗癌药转运形式来提高肿瘤化疗选择性的实验。

Experiments to increase the selectivity of tumor chemotherapy by means of in vivo activation of transport forms of cancerostatics by exogenous enzymes.

作者信息

Graffi A, Arnold W, Sydow G, Schwabe K, Arndt D, Pehl E

出版信息

Neoplasma. 1978;25(4):377-84.

PMID:29245
Abstract

A significant tumor damaging effect (growth inhibition) on transplanted syngeneic sarcoma in mouse was obtained by means of pH-dependent activation of a transport form of a cancerostatic drug by an enzyme foreign to the organism. This effect was achieved by combined administration of 8-0-(alpha-L-arabinofuranosyl)beta-peltatin-A as a transport form of beta-peltatin-A and the exogenous enzyme alpha-L-arabinofuranosidase from Aspergillus niger and additional increase of the acidity of the tumor by injection of glucose. The combined application of the transport form plus enzyme showed a more favorable effect on selectivity than free peltatin when a quantitative comparison was made between the tumor growth inhibition and the damage to the blood picture.

摘要

通过机体外源性酶对一种抗癌药物转运形式的pH依赖性激活,可对小鼠移植同基因肉瘤产生显著的肿瘤损伤效应(生长抑制)。这种效应是通过联合给予作为β-盾叶鬼臼毒素转运形式的8 - O -(α - L - 阿拉伯呋喃糖基)β - 盾叶鬼臼毒素A和来自黑曲霉的外源性酶α - L - 阿拉伯呋喃糖苷酶,并通过注射葡萄糖额外增加肿瘤酸度来实现的。当对肿瘤生长抑制和血液图像损伤进行定量比较时,转运形式加酶的联合应用比游离鬼臼毒素对选择性表现出更有利的效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验